ライフサイエンスコーパス: ferrous sulfate

1 ling, which was blocked by pretreatment with ferrous sulfate.

2 L (95% CI, 6.2 to 14.1 ng/mL; P < .001) with ferrous sulfate.

3 er oral supplementation with 2 mg/kg iron as ferrous sulfate.

4 in a meal was as well absorbed as iron from ferrous sulfate.

5 compare it with the absorption of iron from ferrous sulfate.

6 rrin (whether heat-treated or untreated) and ferrous sulfate.

7 domized order with 59Fe as lactoferrin or as ferrous sulfate.

8 and to compare it with iron absorption from ferrous sulfate.

9 12 wk of supplementation with 50 mg Fe/d as ferrous sulfate.

10 entation with 10 mg elemental iron as HIP or ferrous sulfate.

11 vised daily oral supplementation with HIP or ferrous sulfate.

12 for 10 H. pylori strains, the combination of ferrous sulfate (0.025%), sodium pyruvate (0.025%), and

13 e: 2.6-13.6%), 4 times higher than that from ferrous sulfate (1.7%; range: 1.0-3.3%; P < 0.05).

14 eral ferritin (22.2 +/- 19.2%) compared with ferrous sulfate (16.7 +/- 7.1%).

15 iven lactoferrin (20.4 +/- 15.3%; n = 20) or ferrous sulfate (18.8 +/- 13.2%; n = 20) also was not si

16 igned to receive a 3-mo course of daily oral ferrous sulfate (2 mg . kg-1 . d-1) either concurrently

17 enrollment (intervention group) or SOC oral ferrous sulfate, 200 mg twice daily (approximately 120 m

18 tin (x +/- SD: 21.4 +/- 14.7%) compared with ferrous sulfate (21.9 +/- 14.6%), or high-phosphate iron

19 iron polymaltose (500 mg single dose) or PO ferrous sulfate (210 mg elemental iron daily, continuous

20 n-casein complex (3.4%; 1.4%, 5.4%) and from ferrous sulfate (3.9%; 1.7%, 6.1%) were not statisticall

21 intravenously (IV) every 3 weeks, oral daily ferrous sulfate 325 mg, or oral placebo for 16 weeks.

22 Oral iron (ferrous sulfate 325 mg/d or on alternate days) is typica

23 taining 5 mg Fe as (57)FeFum+Na(58)FeEDTA or ferrous sulfate ((54)FeSO4).

24 evaluated, occurred in the presence of 0.05% ferrous sulfate and 0.05% sodium pyruvate.

25 n foods were highly fortified with iron from ferrous sulfate and ascorbic acid, than did control subj

26 ycinate is better absorbed than is iron from ferrous sulfate and does not exchange with iron from mai

27 The addition of either ferrous sulfate and sodium pyruvate or mucin to brain he

28 ts consumed a test drink with 6 mg (57)Fe as ferrous sulfate and were intravenously infused with 100

29 ive (amyloid beta-peptide, 4-hydroxynonenal, ferrous sulfate) and excitotoxic (glutamate) insults.

30 e of stimulant laxatives and high-dosages of ferrous sulfate, and a significant relationship between

31 Iron, supplied as ferrous sulfate, as ferric chloride, or as holo-transfer

32 /dL (95% CI, 0.4 to 1.6 g/dL; P < .001) with ferrous sulfate (based on a linear mixed model).

33 ths with nutritional iron-deficiency anemia, ferrous sulfate compared with iron polysaccharide comple

34 el) food product was 1.7 times that from the ferrous sulfate-containing (standard) product (P = 0.015

35 the iron-casein complex relative to that of ferrous sulfate (control) when given with whole milk in

36 The interventions provided 7.0-7.5 mg ferrous sulfate/d.

37 mg/kg of elemental iron once daily as either ferrous sulfate drops or iron polysaccharide complex dro

38 iendly and cost-effective high-concentration ferrous sulfate electrolyte using urea as a hydrotropic

39 e whether iron from ferrous bisglycinate and ferrous sulfate exchanges in the intestinal pool; and to

40 iron from ferrous chloride, ferric chloride, ferrous sulfate, ferric ammonium citrate, ferrous ammoni

41 is study was to compare iron absorption from ferrous sulfate, ferrous bisglycinate, and ferric trisgl

42 Two common fortificants are ferrous sulfate (FeSO4) and ferric sodium EDTA (NaFeEDTA

43 transferrin-bound iron (NTBI) in the form of ferrous sulfate (FeSO4), ferric nitrilotriacetate, or tr

44 ize meal fortified with isotopically labeled ferrous sulfate (FeSO4; study 1) or ferric pyrophosphate

45 However, HIP is superior to ferrous sulfate for 5 secondary measures of iron status

46 In study 1B, these volunteers consumed ferrous sulfate-fortified porridge equilibrated with (59

47 This study evaluated the various iron forms, ferrous sulfate (FS), ferrous gluconate (FG), ferric sod

48 complete resolution of IDA was higher in the ferrous sulfate group (29% vs 6%; P = .04).

49 arrhea in the iron complex group than in the ferrous sulfate group (58% vs 35%, respectively; P = .04

50 e prevalence went from 83.7% to 46.2% in the ferrous sulfate group and from 84.6% to 47.1% in the HIP

51 hemoglobin increased from 7.9 to 11.9 g/dL (ferrous sulfate group) vs 7.7 to 11.1 g/dL (iron complex

52 group), 59 completed the trial (28 [70%] in ferrous sulfate group; 31 [78%] in iron polysaccharide c

53 Redox titration indicated that the ferrous sulfate heptahydrate calibrator recommended by B

54 In addition, ferrous sulfate heptahydrate induced a biphasic increase

55 r demetallization, we use a safer and milder ferrous sulfate-hydrochloric acid method in addition to

56 n-casein complex was compared with that from ferrous sulfate in 21 healthy women aged 20-38 y with no

57 s iron bioavailability comparable to that of ferrous sulfate in healthy young women.

58 led, ((57)Fe)-labelled, or ((58)Fe)-labelled ferrous sulfate in iron-depleted (serum ferritin </=25 m

59 nd does not exchange with iron from maize or ferrous sulfate in the intestinal pool.

60 inactivated by micromolar concentrations of ferrous sulfate in the presence of ascorbate at pH 7.4.

61 supplemented with (59)Fe-labeled ferritin or ferrous sulfate, in randomized order.

62 n is equally well absorbed from ferritin and ferrous sulfate independent of the phosphate content of

63 Compared with oral ferrous sulfate, intravenous iron sucrose improved both

64 Ferrous sulfate is the most commonly prescribed oral iro

65 oral administration of aqueous solutions of ferrous sulfate isotopically labeled with (5)(4)Fe, (5)(

66 ence in iron absorption between ferritin and ferrous sulfate: low-phosphate iron mineral ferritin (x

67 vengers N-methyl-D-glucamine dithiocarbamate/ferrous sulfate mixture (MGD-Fe) or 2-(4-carboxyphenyl)-

68 etermine the effect of an oral supplement of ferrous sulfate on free radical generation.

69 ron (7 mg/d as multivitamin preparation with ferrous sulfate) or placebo (multivitamin preparation wi

70 -50 mug/dL [95% CI, -86 to -14 mug/dL] with ferrous sulfate; P < .001).

71 stent with heating and oxidation of hydrated ferrous sulfates, potentially through deposition of lava

72 Ferrous sulfate reversed the CoPP-induced decrease in ma

73 Once daily, low-dose ferrous sulfate should be considered for children with n

74 i in broth was determined in the presence of ferrous sulfate, sodium pyruvate, and mucin (porcine sto

75 scorbic acid replaces the traditionally used ferrous sulfate to reduce the phosphomolybdate complex.

76 viding 0.9 mg 58Fe as FeSO4) and 6.8 mg 57Fe ferrous sulfate tracer administered with a nonheme food

77 itin level increased from 3.0 to 15.6 ng/mL (ferrous sulfate) vs 2.0 to 7.5 ng/mL (iron complex) over

78 g capacity decreased from 501 to 389 mug/dL (ferrous sulfate) vs 506 to 417 mug/dL (iron complex) (a

79 lability value of the iron-casein complex to ferrous sulfate was determined to be 0.87 (-1 SD, +1 SD:

80 To accelerate lipid oxidation, ferrous sulfate was encapsulated in W(1).

81 idence for other interventions compared with ferrous sulfate was insufficient.

82 cts when they received either lactoferrin or ferrous sulfate, which suggested that iron is absorbed f

83 To compare the effect of ferrous sulfate with iron polysaccharide complex on hemo

84 lement containing 32 mg elemental iron (from ferrous sulfate) with a lunch meal containing either 4 o